NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Genomic Testing and Resulting Medical Decisions

CompletedN/A

Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie

Conditions: Cancer of Unknown Origin, Cancer Refractory, Cancer of Stomach, Cancer Head Neck, Cancer of Skin

Interventions: Genomic testing

Countries: Austria

There is no evidence available about which molecular profiling methods are currently used for cancer patients in Austrian clinical practice. The construction of the registry proposed as a completely independent research endeavor, will be helpful for scientific evaluation and the establishment of highly credible data.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

This registry will include cancer patients for which broad genomic profiling is indicated as assessed by the medical need and as deemed appropriate by the physician, for example

* cancer with high mutational load and suspicion of regular or frequent formation of neoantigens

  * skin, lung, stomach, esophagus, colorectum, bladder, uterus, cervix, liver, head and neck, kidney, breast
  * lymphoma B-cell
* any other neoplastic disease where molecular targeting is performed but treatment fails
* cancer of unknown primary origin (CUP)
* planned or already carried out comprehensive genomic testing as of Jan 1, 2016 note: this registry will not initially register patients who are tested for only 1-5 mutations by conventional means, but patients undergoing genomic profiling based on NGS)
* a patient´s signed informed consent
* Patients ≥ 18 years of age

Exclusion Criteria:

* Due to the non-interventional design of the registry there are no specific exclusion criteria.

Locations (11)

Salzburg, State of Salzburg, Austria
Feldkirch, Austria
Graz, Austria
Innsbruck, Austria
Krems, Austria
Linz, Austria
Sankt Pölten, Austria
Vienna, Austria
Vöcklabruck, Austria
Wels, Austria
Zams, Austria